Why Coombs Test is Positive in Hemolytic Disease of Newborn
A positive Coombs test (Direct Antiglobulin Test or DAT) in Hemolytic Disease of the Newborn (HDN) indicates the presence of maternal antibodies bound to the newborn's red blood cells, confirming antibody-mediated hemolysis as the cause of the infant's condition.
Mechanism of Positive Coombs Test in HDN
The Direct Antiglobulin Test (DAT) works by detecting antibodies that are already bound to the surface of red blood cells. In HDN, this occurs through the following process:
Maternal Alloimmunization:
- The mother develops antibodies against fetal red blood cell antigens that she lacks
- These antibodies cross the placenta during pregnancy
Antibody Binding:
- Maternal IgG antibodies attach to specific antigens on the fetal/newborn red blood cells
- Common targets include:
- Rh antigens (particularly D antigen)
- ABO blood group antigens
- Other minor blood group antigens
Detection by DAT:
- The Coombs reagent (anti-human globulin) binds to these maternal antibodies on the newborn's red cells
- This binding causes visible agglutination, resulting in a positive test
Common Causes of Positive DAT in HDN
ABO Incompatibility:
- Most common cause (73.6% of positive DAT cases) 1
- Typically occurs when mother is blood group O and baby is group A or B
- Maternal anti-A or anti-B IgG antibodies bind to the newborn's red cells
Rh Incompatibility:
- Occurs when Rh-negative mother develops anti-D antibodies against Rh-positive fetal cells
- Usually happens after previous sensitization during pregnancy or delivery
- Can cause severe HDN requiring exchange transfusion 2
Other Alloantibodies:
- Anti-S, anti-Kell, anti-Duffy, anti-Kidd, anti-Diego and others
- These minor blood group incompatibilities account for approximately 20.4% of positive DAT cases 1
- Can cause varying degrees of hemolysis
Clinical Significance of Positive DAT
A positive DAT in a newborn with jaundice suggests:
- Ongoing hemolysis due to maternal antibodies
- Need for monitoring bilirubin levels and hemoglobin
- Potential requirement for treatment including:
Important Considerations
False Negative Results:
- Low antibody levels may not cause a strongly positive DAT
- Weak D antigens may cause hemolysis despite negative routine testing 3
Unusual Cases:
Follow-up Testing:
- According to guidelines, infants with positive DAT who received phototherapy should have follow-up TSB measurement 8-12 hours after discontinuation and on the following day 6
- Monitoring for rebound hyperbilirubinemia is essential
Management Implications
When a positive DAT is identified in a newborn:
Evaluate for hemolysis:
- Monitor bilirubin levels (TSB) every 4-6 hours initially
- Watch for rapid rise (≥0.3 mg/dL per hour in first 24 hours) suggesting ongoing hemolysis 6
- Check hemoglobin and reticulocyte count
Initiate treatment based on bilirubin levels:
- Phototherapy at appropriate thresholds based on gestational age and risk factors
- Consider IVIG for severe cases
- Prepare for exchange transfusion if bilirubin approaches exchange threshold
Identify the specific antibody:
- Perform antibody identification on maternal serum
- Elution studies from infant's red cells may help identify the antibody
By understanding why the Coombs test is positive in HDN, clinicians can better anticipate the clinical course and provide appropriate monitoring and treatment to prevent complications like kernicterus.